NCT02603497

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Pharmacokinetic (PK) Study of ASP015K -Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Subjects With Normal Renal Function-

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to compare the pharmacokinetics of ASP015K in patients with impaired renal function and subjects with normal renal function.

Conditions

• Patients With Impaired Renal Function

Interventions

Type	Name	Description
DRUG	ASP015K	oral

Timeline

• Start date: 2015-11-24
• Primary completion: 2016-12-19
• Completion: 2016-12-19
• First posted: 2015-11-11
• Last updated: 2024-10-16

Locations

2 sites across 1 country: Japan